Projects

"Reducing AIDS stigma among health professionals in India" using an innovative Informatics approach (Project DriSti)

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2019 - 2021

Project Lead

Authors

Maria L Ekstrand a,b,*, Tony Raj b, Elsa Heylen a, Laura Nyblade c, Dhinagaran Devdass b, Matilda Pereira b, Amanda Mazur a, Krishnamachari Srinivasan

Project Status

completed